Newsletter Archive
-
04.11.24 -- New DSCSA Guidance Details Layers Of Verification System Requirements
4/11/2024
04/11/24 Bioprocess Online Newsletter
-
04.10.24 -- Considerations For Robust Implementation Of The Multi-Attribute Method
4/10/2024
04/10/24 Bioprocess Online Newsletter
-
04.09.24 -- Comparability Considerations For mRNA Product Development
4/9/2024
04/09/24 Bioprocess Online Newsletter
-
04.08.24 -- What Proposed Plasmid DNA Standards Say For GMP/Non-GMP Production
4/8/2024
04/08/24
-
04.05.24 -- New Episodes: Allogeneic Cell Therapy Toxicities (and how to reduce them); Biotech and The Innovator's Dilemma.
4/5/2024
04/05/24 Bioprocess Online Newsletter
-
04.05.24 -- Process Development With “The End In Mind” For Startups
4/5/2024
04/05/24 Bioprocess Online Newsletter
-
04.04.24 -- Optimize Your Use Of Cell Culture Media Analysis
4/4/2024
04/04/24 Bioprocess Online Newsletter
-
04.04.24 -- 2024 LIMS Trends
4/4/2024
04/04/24 Bioprocess Online Newsletter
-
04.03.24 -- Streamline Your Outsourcing Journey & Discover Top CDMOs
4/3/2024
04/03/24 Bioprocess Online Newsletter
-
04.03.24 -- See how Organ-Chips are Transforming Drug Development for Cancer, Toxicology, Cell & Gene Therapy, and More!
4/3/2024
04/03/24 Bioprocess Online Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more